The drug failed to show any significant benefit in patient requiring mechanical ventilation
The drug failed to show any significant benefit in patient requiring mechanical ventilation
Watch the show from 4pm at pmlive.com/cxhealth
Siltuximab is a monoclonal antibody that directly neutralises interleukin (IL)-6, an inflammatory cytokine
The NIHR CRN supported 1,580 commercial studies in 2019/20
This marks the first major regulatory approval of a vaccine developed by Janssen
ViiV received more than 400 applications from across the world, with eligible submissions coming from Africa, Asia, Europe, South America and the US
In a clinical trial, Bavencio maintenance treatment extended median overall survival by 50% over standard of care
Consultant ophthalmologists at Spire hospital conspired to fix prices for private consultations
CF patients in England will be among the first in Europe to benefit from access to Kaftrio, if the medicine is approved by the EC
The funds will enable in-house drug discovery across a number of therapeutic areas including cancer and neurodegeneration
The collaboration hopes to empower patients to take more control of their own health
The therapy marks Roche’s first combination of two monoclonal antibodies administered in a single subcutaneous injection
Almost all cancer trials in Scotland are on hold amid the coronavirus pandemic
The study will assess the potential of the drug in patients hospitalised with severe SARS-CoV-2 infection and pneumonia
UCL researchers find a 31% increased risk of dementia in those with high BMI